AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Archives: News
Five use cases for blockchain in pharma Pharmaphorum
As blockchain expands its reach across different industries, Gunjan Bhardwaj examines some of its practical applications in the pharma industry. Blockchain is quickly increasing in interest and has received praise for its far-reaching applications, mainly because of its recent expansion into industries ranging from financial services to energy suppliers and pharmaceutical companies. It is a …
Five use cases for blockchain in pharma Pharmaphorum Read More »
TiE Inflect 2018 announces Innoplexus AG as a 2018 TiE50 Finalist
April 23, 2018 – Eschborn – Innoplexus AG is excited to announce that it has been selected as a “2018 TiE50 Finalist” for the prestigious TiE50 Awards Program recognizing the world’s most innovative tech startups. This awards competition is part of TiE Inflect 2018, the world’s largest conference for tech entrepreneurs. Innoplexus is helping organisations move …
TiE Inflect 2018 announces Innoplexus AG as a 2018 TiE50 Finalist Read More »
Third Wave of Artificial intelligence promises the first AI Summit organised by Innoplexus and Frankfurt School of Finance & Management
Insights into the Third Wave of Artificial intelligence promises the first AI Summit organised by Innoplexus and Frankfurt School of Finance & Management On June 18, 2018, the first annual AI summit jointly organised by Frankfurt School of Finance & Management and Innoplexus will take place at the campus of Frankfurt School. Among other activities, Frankfurt School …
Drug Prices Are Too Expensive: Here’s How Technology Can Fix That Forbes Technology Council
Post Written ByGunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. The cost of drug development has skyrocketed, but disruptive technologies can bring it back down to earth. Over the past several decades, drug-development costs have risen significantly, from $250 million per approved drug prior to the 1990s to $403 million …
Can blockchain solve pharma’s counterfeit drug problem? Pharmaphorum
Nobody doubts that fake medicines are an increasing threat to consumers and the pharma industry’s bottom line. Is blockchain the answer to secure the supply chain? Counterfeit medicines are a multi-billion dollar problem on a global level. From the size, shape and colour of the pharmaceuticals, to the packaging made to look like the real …
Can blockchain solve pharma’s counterfeit drug problem? Pharmaphorum Read More »
How Innoplexus uses smart and on-edge technology to help its pharma clients find relevant answers hidden in unstructured data
When a major global pharmaceutical company wanted to accelerate the development of a new therapy line and discover how to differentiate their early stage assets, they approached Innoplexus. That decision could not have been more apt. Since its inception in 2011, the Indo-German company has been working to help transform the global healthcare market, especially focussing on …
Leveraging AI and Blockchain to Transform Healthcare
Medicine is ripe for disruption. As David Lawrence, former Chairman and CEO of the Kaiser Foundation Health Plan, wrote in his 2005 book chapter Bridging the Quality Chasm: “Between $.30 and $.40 of every dollar spent on healthcare is spent on the costs of poor quality. This extraordinary number represents slightly more than a half-trillion dollars …
Leveraging AI and Blockchain to Transform Healthcare Read More »
How Blockchain Can Improve the Pharma Manufacturing Supply Chain Pharmaphorum
The entire pharmaceutical industry has been booming, from the manufacturing of clinical trial materials to support research studies to the regulated medicines on the pharmacy shelves. It has been one of the top industry performers of the past three decades. By maintaining the highest safety and quality standards, many pharma business units along the supply …
How Blockchain Can Improve the Pharma Manufacturing Supply Chain Pharmaphorum Read More »
Why pharma companies need to upgrade their intelligence Pharmaphorum
In the 21st century pharma companies face novel challenges. Pairing artificial intelligence (AI) capabilities with human strengths can bring a competitive edge in this rapidly–changing world. As the Nobel-prize-winning economist Daniel Kahneman wrote in his book Thinking, Fast and Slow, “Intelligence is not only the ability to reason; it is also the ability to find relevant …
Why pharma companies need to upgrade their intelligence Pharmaphorum Read More »